Skip to main content

Advertisement

Table 1 (abstract O09). Comparison of clinical parameters and SLICC-SDI scores following MMF vs CYC treatment

From: Proceedings of the 25th European Paediatric Rheumatology Congress (PReS 2018)

Time post biopsy* Outcome parameter MMF induction CYC induction p
10-14 Renal BILAG score A=1, B=5, C=3, D=18 A=1, B=3, C=2, D=8 1.00
UACR** 13[4-42] 21[3–56] 0.99
Serum creatinine 59[51-69] 62[50-73] 0.32
ESR 12[5–21] 20[4–49] 0.62
dsDNA 44[24-95] 20[6-440] 0.84
C3 0.98[0.81-1.18] 1.04[0.92–1.34] 0.20
Patient global 4.5[0–9.3] 3.0[0.5–52.0] 0.98
Physician global 7.0[1.3–14.0] 9.9[3.0–24.0] 0.66
13*** SLICC SDI 0[0-1] 0[0–2.5] 0.67
  1. *Months. **Urinary albumin/creatinine ratio. ***SLICC SDI score after a median of 13 months post renal biopsy (range 10-18)